Last update: March 22, 2018
Not risky for breastfeeding or infant.
Opioid drug derived from pethidine.
Contraindicated for those children younger than 2 year old.
Indiscriminate use for treatment of gastroenteritis is not justified. Most acute diarrheic disorders are self-limijted conditions. WHO’s Oral Rehydration Solutions and appropriate nutritional support are recommended.
Excreted into breast milk in non-significant levels. Its low oral bioavailability makes it difficult to acceed the infant serum.
American Academy of Pediatrics: medication usually compatible with breastfeeding (AAP 2001).
We do not have alternatives for 4-(4-p-Chlorophenyl-4-hydroxypiperidino)-NN-dimethyl-2,2-diphenylbutyramide hydrochloride since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM